Inappropriate antidiuretic hormone secretion and rhabdomyolysis associated with citalopram.
Zullino
D
D
Brauchli
S
S
Horvath
A
A
Baumann
P
P
D000855:Anorexia / Q000139:chemically induced; D014150:Antipsychotic Agents / Q000627:therapeutic use; D002749:Chlorprothixene / Q000627:therapeutic use; D015283:Citalopram / Q000009:adverse effects* / Q000627:therapeutic use; D003221:Confusion / Q000139:chemically induced; D003402:Creatine Kinase / Q000097:blood; D003865:Major Depressive Disorder / Q000188:drug therapy; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007177:Inappropriate ADH Syndrome / Q000139:chemically induced*; D007527:Isoenzymes / Q000097:blood; D008875:Middle Aged; D011188:Potassium / Q000097:blood; D012206:Rhabdomyolysis / Q000139:chemically induced*; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D012964:Sodium / Q000097:blood
D014150:Antipsychotic Agents; D002749:Chlorprothixene; D015283:Citalopram; D003402:Creatine Kinase; D007527:Isoenzymes; D011188:Potassium; D017367:Selective Serotonin Reuptake Inhibitors; D012964:Sodium